| Name | Title | Contact Details |
|---|
Based in Chicago, BrightStar Care is a national private duty home care and medical staffing franchise with more than 280 locations that can provide medical and non-medical services to clients within their homes, as well as supplemental care staff to corporate clients. BrightStar Care professional nurses and caregivers deliver expert, compassionate, and personal care 24 hours a day, 7 days a week. Each BrightStar Care location is required to pursue Joint Commission Accreditation. BrightStar Care received The Joint Commission`s Enterprise Champion for Quality award in 2013, 2014, and 2015, and is committed to having each of its agencies comply with Joint Commission standards. BrightStar Care uses the nationally known patient satisfaction survey company Press Ganey to measure client satisfaction and is proud that nine out of 10 clients would recommend BrightStar Care to a friend or family member.
Salick Health Care is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
AllerVie Health is a national network of board-certified allergists and immunologists partnering together for the advancement of patient care, serving patients across 12 states in 76 clinic locations. Our providers are committed to establishing the allergy and immunology gold standard, expanding access to best-in-class care, and bringing relief and renewed vitality to the millions of Americans affected annually, many of whom live in underserved communities today. AllerVie is relentlessly dedicated to clinical excellence, creating an improved patient experience, and supporting the development of advanced allergy and immunology-focused therapeutics and treatment options. With AllerVie Health, our patients can feel their best, reclaim their lives, and live in freedom!
KaloBios is a biopharmaceutical company dedicated to helping the lives of patients with innovative therapies. Our mission is to improve the lives of cancer patients with innovative, Humaneered®, monoclonal antibodies. KaloBios` Humaneered® antibodies are next generation, customized antibodies designed to overcome challenges limiting today`s marketed antibody products. Using our expertise, our antibodies are customized to enhance a desired effect or reduce a possible undesired effect. Our pipeline is comprised of Humaneered® antibodies. These antibodies are being investigated in clinical development programs focused on treating cancer: KB004 (anti-EphA3) Humaneered® mAb to treat patients with hematologic malignancies, solid tumors, and their stem cells; currently enrolling patients with myelofibrosis and myelodysplastic syndrome in the company’s Phase 2 expansion portion of its Phase 1/2 clinical trial in hematologic malignancies; and KB003 (anti-GM-CSF) Humaneered® mAb that KaloBios intends to evaluate in oncology indications where GM-CSF may play a key role in such indications as chronic myelomonocytic leukemia (CMML). KaloBios intends to commence clinical evaluation of KB003 in this patient population beginning in the second half of 2015. We use a patient-targeted approach utilizing or developing a screen or diagnostic method to identify those patients most likely to benefit from our treatments.
RAAS BLOOD PRODUCTS CO., LTD. is a Agoura Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.